These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38853772)
1. Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy. Nollet EE; Schuldt M; Sequeira V; Binek A; Pham TV; Schoonvelde SAC; Jansen M; Schomakers BV; van Weeghel M; Vaz FM; Houtkooper RH; Van Eyk JE; Jimenez CR; Michels M; Bedi KC; Margulies KB; Dos Remedios CG; Kuster DWD; van der Velden J Circ Genom Precis Med; 2024 Jun; 17(3):e004369. PubMed ID: 38853772 [TBL] [Abstract][Full Text] [Related]
2. Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics. Tucholski T; Cai W; Gregorich ZR; Bayne EF; Mitchell SD; McIlwain SJ; de Lange WJ; Wrobbel M; Karp H; Hite Z; Vikhorev PG; Marston SB; Lal S; Li A; Dos Remedios C; Kohmoto T; Hermsen J; Ralphe JC; Kamp TJ; Moss RL; Ge Y Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24691-24700. PubMed ID: 32968017 [TBL] [Abstract][Full Text] [Related]
14. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784 [TBL] [Abstract][Full Text] [Related]
15. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320 [TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy. Coats CJ; Heywood WE; Virasami A; Ashrafi N; Syrris P; Dos Remedios C; Treibel TA; Moon JC; Lopes LR; McGregor CGA; Ashworth M; Sebire NJ; McKenna WJ; Mills K; Elliott PM Circ Genom Precis Med; 2018 Dec; 11(12):e001974. PubMed ID: 30562113 [TBL] [Abstract][Full Text] [Related]
17. Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier. Nollet EE; Westenbrink BD; de Boer RA; Kuster DWD; van der Velden J J Am Heart Assoc; 2020 Nov; 9(22):e018641. PubMed ID: 33174505 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration. Nollet EE; Duursma I; Rozenbaum A; Eggelbusch M; Wüst RCI; Schoonvelde SAC; Michels M; Jansen M; van der Wel NN; Bedi KC; Margulies KB; Nirschl J; Kuster DWD; van der Velden J Eur Heart J; 2023 Apr; 44(13):1170-1185. PubMed ID: 36734059 [TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy. Bottillo I; D'Angelantonio D; Caputo V; Paiardini A; Lipari M; De Bernardo C; Giannarelli D; Pizzuti A; Majore S; Castori M; Zachara E; Re F; Grammatico P Gene; 2016 Feb; 577(2):227-35. PubMed ID: 26656175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]